CLINICAL_TRIALS
trial_result
· 2013-01-31
Clinical Trial Update: FR901228 in Treating Patients With Hematologic Cancer [Phase 1]
Summary
This Phase 1 trial update reports the completion of a study of FR901228 in patients with hematologic cancers, including leukemia and lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED